Correspondence | Published:

Response to Juang et al.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Juang C-M, Don S-J, Hwu W-L et al. Fabry disease cardiac variants IVS4+919G>A is associated with multiple cardiac gene mutations in patients with severe cardiomyopathy and fatal arrhythmia. Genet Med. 2019.

  2. 2.

    Hsu M-J, Chang F-P, Lu Y-H, et al. Identification of lysosomal and extralysosomal globotriaosylceramide (Gb3) accumulations before the occurrence of typical pathological changes in the endomyocardial biopsies of Fabry disease patients. Genet Med. 2018 Jun 6; https://doi.org/10.1038/s41436-018-0010-z. [Epub ahead of print].

  3. 3.

    Nakao S, Takenaka T, Maeda M, et al. An atypical variant of Fabry’s disease in men with left ventricular hypertrophy. N Engl J Med. 1995;333:288–293.

  4. 4.

    Spada M, Pagliardini S, Yasuda M, et al. High incidence of later-onset fabry disease revealed by newborn screening. Am J Hum Genet. 2006;79:31–40.

  5. 5.

    Inoue T, Hattori K, Ihara K, Ishii A, Nakamura K, Hirose S. Newborn screening for Fabry disease in Japan: prevalence and genotypes of Fabry disease in a pilot study. J Hum Genet. 2013;58:548–552.

  6. 6.

    Hsu T-R, Sung S-H, Chang F-P, et al. Endomyocardial biopsies in patients with left ventricular hypertrophy and a common Chinese later-onset fabry mutation (IVS4+919G>A). Orphanet J Rare Dis. 2014;9:96.

  7. 7.

    Hsu TR, Hung SC, Chang FP, et al. Later onset Fabry disease, cardiac damage progress in silence: experience with a highly prevalent mutation. J Am Coll Cardiol. 2016;68:2554–2563.

  8. 8.

    Sachdev B, Takenaka T, Teraguchi H, et al. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation. 2002;105:1407–1411.

  9. 9.

    Monserrat L, Gimeno-Blanes JR, Marín F, et al. Prevalence of fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2007;50:2399–2403.

  10. 10.

    Elliott P, Baker R, Pasquale F, et al. Prevalence of Anderson–Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson–Fabry Disease Survey. Heart. 2011;97:1957.

  11. 11.

    Chiang H-L, Wang NH-H, Song I-W, et al. Genetic epidemiological study doesn’t support GLA IVS4+919G>A variant is a significant mutation in Fabry disease. Mol Genet Metab. 2017;121:22–27.

Download references

Author information

Correspondence to Chia-Lin Hsu PhD or Dau-Ming Niu MD, PhD.

Ethics declarations

Disclosure

The authors declare no conflicts of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark